Category Archives: Infectious diseases

Biden releases national strategy intended to beat COVID-19 pandemic

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

President Joe Biden wears a mask in a social media image announcing a mask mandate on federal property, launching his “100 Day Masking Challenge” as part of our efforts to flatten the COVID-19 curve.

President Joe Biden wears a mask in a social media image announcing a mask mandate on federal property, launching his “100 Day Masking Challenge” as part of the country’s efforts to flatten the COVID-19 curve.

On Jan. 21, President Biden published a 200-page national plan for combating the COVID-19 pandemic and preparing for the next one.

It is a stark contrast to former President Trump, whose coronavirus task force never created a national plan for responding to the pandemic and instead left it up to states and their health departments to determine strategies for ending the pandemic, resulting in a patchwork of plans that did little to stop the pandemic.

Biden put federal heft behind his national plan, directing agencies to focus on seven goals: Continue reading

Reporting responsibly on COVID-19 vaccines requires knowing the research landscape

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

Coronavirus CG Illustration

Photo: Yuri Samoilov via Flickr

A new New York Times perspective piece on whether we’re underselling the various COVID-19 vaccines had public health Twitter abuzz on Jan. 18, with responses ranging from high fives to intense critique. My reaction was in the latter camp. The points I made in this thread (unrolled here) are essential to consider for all journalists reporting on all vaccines and for this virus in particular. I’ve touched on these issues multiple times in the past, particularly the importance of knowing:

Continue reading

Toolkit offers COVID-19 vaccine story ideas, survey findings on vaccine attitudes

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

One of the video resources available at the NAB-RJI Vaccine Education Toolkit.

Image & video: NAB-RJI Vaccine Education ToolkitOne of the video resources available at the NAB-RJI Vaccine Education Toolkit.

Journalists reporting on the rollout of the COVID-19 vaccine have a new tool to guide their coverage: a Vaccine Education Toolkit that includes survey results on audience attitudes and needs, B-roll and multimedia, webinars, recommended experts and tips on reaching specific audiences. This resource may be a helpful complement to the AHCJ’s extensive resources on reporting about the pandemic.

The bilingual website was developed by three groups: the National Association of Broadcasters (NAB), the Donald W. Reynolds Journalism Institute (RJI) and the National Association of Chain Drug Stores (NACDS). RJI is a part of the Missouri School of Journalism and the NACDS is an industry trade group representing traditional drug stores, supermarkets and mass merchants with pharmacies. Continue reading

Major COVID-19 vaccine ad campaign to roll out next week

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

Dr. Anthony Fauci getting his vaccination.

Photo: NIAID via FlickrDr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, received his COVID-19 vaccination.

Journalists covering the COVID-19 vaccine rollout should watch out on Jan. 21 for the Ad Council’s unveiling of an advertising campaign to increase the public confidence getting vaccinated.

The nonprofit group, which led the advertising campaign to garner public support for the polio vaccine in the 1950s, plans to focus especially on communities of color, which polls show are skeptical of the vaccine. Continue reading

Court settlement grants Florida paper access to COVID-19 reports

About Naseem Miller

Naseem S. Miller (@NaseemMiller) is in her final week as senior reporter, health, at the Orlando Sentinel. On Jan. 19, she will start as senior editor, health at Journalist’s Resource.

scales of justiceThe state of Florida last week settled a lawsuit with the Orlando Sentinel, agreeing to provide weekly COVID-19 reports within two days and pay the newspaper’s legal costs.

It was a victory for the newspaper, and for press freedom. Our experience contains lessons – and encouragement – for other newsrooms facing obstruction by state or local officials.

Before filing suit, we persistently sought the documents for weeks, through informal and formal channels. We repeatedly told our readers about our efforts and the state’s decision to withhold information, keeping the issue alive in the public’s eye. Continue reading

Long-term effects of COVID-19 on the brain could mean a wave of dementia cases

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

LongCOVID

Photo: Neil Moralee via Flickr

We don’t yet know the severity of COVID-19’s long-term effects on the brain, but a group of international researchers is aiming to find out.

The Alzheimer’s Association and scientists in 30 countries are forming an international consortium to track and assess COVID-19 patients. According to a paper announcing the study, scientists will look for any lasting effects on the central nervous system which may lead to late-life cognitive decline, including Alzheimer’s disease, Parkinson’s disease and other brain disorders. The World Health Organization is providing technical help. Continue reading